News | Kedrion
You are now leaving the Kedrion website. The information available in your chosen website may not be in compliance with EU legislation regulating the advertising of medicinal products for human use, nor do the opinions expressed necessarily reflect the Company’s positions or are endorsed by it.
NO
YES

HIGHLIGHTS

CORPORATE

Kedrion-Kamada collaboration for Anti Covid-19 IgG

The companies announced cooperation for developing Anti Covid-19 therapy

read more 

CORPORATE

Letter to patient associations and scientific organizations

Communication from Paolo Marcucci, Chairman & CEO of Kedrion

read more 

EVENTS

Kedrion-supported scientific symposium at the MANIT Conference in Hungary

The company reaffirms its commitment to Hungarian clinicians working in the field of dysimmune neurological diseases

read more 
  1. CORPORATE - 29-04-2020

    Kedrion-Kamada collaboration for Anti Covid-19 IgG

    The companies announced cooperation for developing Anti Covid-19 therapy

    read more 
  2. CORPORATE - 15-04-2020

    Coronavirus - from plasma an anti Covid-19 treatment

    Kedrion’s commitment to find a treatment from convalescent patient plasma

    read more 
  3. CORPORATE - 25-03-2020

    Letter to patient associations and scientific organizations

    Communication from Paolo Marcucci, Chairman & CEO of Kedrion

    read more 

Pages

For more information please contact: pressoffice@humanked.com